Skip to Content

Join the 'Betamethasone / Calcipotriene' group to help and get support from people like you.

Betamethasone / Calcipotriene News

Siliq Approved for Plaque Psoriasis

Posted 2 Mar 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults. Siliq is approved for patients who've already failed to respond to other systemic therapies, the agency noted. The autoimmune disease – so-called because the immune system produces antibodies that attack the body's own tissues – causes thick, scaly patches of red skin. The drug is designed to inhibit the body's inflammatory response that plays a role in the development of plaque psoriasis, the FDA said in a news release. The disease occurs most often in people with a family history, usually between ages 15 and 35. Saliq was evaluated in clinical studies involving more than 4,300 people with moderate-to-severe plaque psoriasis. The most common side effects included joint pain, headache, fatigue, diarrhea, ... Read more

Related support groups: Methotrexate, Psoriasis, Plaque Psoriasis, Soriatane, Dovonex, Tazorac, Taclonex, Oxsoralen, Acitretin, Tazarotene, Calcipotriene, Resorcinol, Methoxsalen, Anthralin, Enstilar, Vectical, Taclonex Scalp, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium

FDA Approves Injectable Psoriasis Drug for Tough Cases

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – A new drug to treat tough cases of the skin condition psoriasis has won approval from the U.S. Food and Drug Administration. Valeant Pharmaceuticals' injectable drug Siliq (brodalumab) was approved for adults with moderate-to-severe psoriasis that isn't responding to other recommended treatments. However, the drug carries a warning about increased risk for suicidal behavior. Psoriasis is characterized by raised patches of red skin and flaking. The condition usually begins between ages 15 and 35 and is thought to be an autoimmune disorder, meaning the body mistakenly attacks healthy cells. "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today's approval provides patients with another treatment option for their psoriasis," said the FDA's Dr. Julie Beitz. Beitz is director of the Office of Drug ... Read more

Related support groups: Methotrexate, Psoriasis, Plaque Psoriasis, Soriatane, Dovonex, Tazorac, Taclonex, Oxsoralen, Acitretin, Tazarotene, Calcipotriene, Resorcinol, Methoxsalen, Anthralin, Enstilar, Vectical, Taclonex Scalp, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium

Health Tip: Caring for Psoriasis on Your Feet

Posted 4 Jan 2017 by Drugs.com

-- Psoriasis causes red, scaly, itchy plaques on the skin, including the feet. The American Podiatric Medical Association suggests these ways to soothe it: Moisturize your feet regularly. Choose a moisturizer that's hypoallergenic and non-irritating. Soak feet in an oatmeal bath. Ask your doctor about special light therapy. Avoid psoriasis triggers, such as alcohol and exposure to dry air. See a podiatrist if your foot psoriasis doesn't improve. Read more

Related support groups: Psoriasis, Plaque Psoriasis, Dovonex, Tazorac, Taclonex, Oxsoralen, Calcipotriene, Tazarotene, Resorcinol, Enstilar, Vectical, Foot Care, Anthralin, Taclonex Scalp, Dritho-Scalp, Psoriatec, Drithocreme, Avage, R A Acne, Sorilux

Even Incomplete Steroid Treatment Helps Preemies: Study

Posted 10 Oct 2016 by Drugs.com

MONDAY, Oct. 10, 2016 – Even partial steroid treatment before birth can improve survival odds for extremely premature infants and reduce their risk of certain birth defects, a new study suggests. Steroids are standard therapy for pregnant women likely to give birth before 34 weeks of gestation. But the complete course of treatment takes at least 48 hours and doctors may decide not to begin treatment if premature delivery is imminent, explained researchers funded by the U.S. National Institutes of Health. But these new findings "suggest that starting steroid treatment promptly – even if the likelihood of completion is low – is beneficial when extremely premature birth is imminent," the researchers said. The investigators analyzed data from more than 6,100 extremely premature infants who were born between 22 and 27 weeks of pregnancy. They were followed for 18 to 22 months after birth. ... Read more

Related support groups: Betamethasone, Delivery, Celestone, Premature Labor, Taclonex, Betamethasone/Clotrimazole, Lotrisone, Beta-Val, Betnovate, Apnea of Prematurity, Luxiq, Diprosone, Betaderm, Cesarean Section, Diprolene, Enstilar, Labor and Delivery including Augmentation, Taclonex Scalp, Prematurity/Underweight in Infancy, Del-Beta

Steroids Might Help More Than Just Very Premature Babies: Study

Posted 4 Feb 2016 by Drugs.com

THURSDAY, Feb. 4, 2016 – Giving steroids to pregnant women at risk for late preterm delivery may reduce the risk of severe respiratory problems in their babies, a new study finds. The study included more than 2,800 pregnant women with a high risk of late preterm delivery (34 to 36 weeks of pregnancy) who were randomly selected to receive two injections over 24 hours of either the steroid betamethasone or a placebo. The steroid is commonly used to prevent complications in babies born before 34 weeks of pregnancy. A full-term pregnancy is considered to be 40 weeks. Compared to babies born to mothers who received the placebo, babies born to mothers who received the steroid were much less likely to have severe respiratory complications shortly after birth, to require a long stay in the neonatal intensive care unit, or to need respiratory treatments. The findings were published Feb. 4 in ... Read more

Related support groups: Betamethasone, Delivery, Celestone, Premature Labor, Labor Induction, Respiratory Tract Disease, Taclonex, Betamethasone/Clotrimazole, Lotrisone, Betnovate, Beta-Val, Labor Pain, Luxiq, Diprosone, Apnea of Prematurity, Betaderm, Diprolene, Enstilar, Labor and Delivery including Augmentation, Taclonex Scalp

Retail Prices of Dermatology Drugs Skyrocket

Posted 25 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 25, 2015 – Patients using prescription creams, gels, sprays and pills for skin conditions may shell out substantially more at the pharmacy than they did just six years ago, a new study suggests. Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, study authors reported Nov. 25 in JAMA Dermatology. Even generics have succumbed to price inflation, up 279 percent between 2011 and 2014, based on the drugs surveyed. Price increases for skin treatments far outpaced the general inflation rate of 11 percent during the six-year study period, the researchers said. "Cancer drugs were the worst in terms of the numbers" – up 1,240 percent or nearly $11,000 over the six-year study period – primarily because of two medicines, said Dr. Steven Rosenberg, voluntary professor of dermatology at the University of Miami Miller School of ... Read more

Related support groups: Monistat, RID, Monistat 3, Eczema, Monistat 7, Voltaren Gel, Dermatitis, Clobetasol, Therapeutic, Contact Dermatitis, Bactroban, Mupirocin, Efudex, Maintain, Sulfur, Drysol, Hypercare, Retin-A, Epiduo, Fluocinonide

LEO Pharma Announces U.S. Approval of Enstilar Foam (calcipotriene/betamethasone dipropionate) for Plaque Psoriasis

Posted 21 Oct 2015 by Drugs.com

Ballerup, Denmark 19 October, 2015: LEO Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Enstilar (calcipotriene/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) Foam for the treatment of psoriasis vulgaris in patients 18 years of age or older in the United States.1 Enstilar is a once-daily, alcohol-free topical treatment.1 “We are very pleased by the U.S. approval of Enstilar and believe it will provide patients with the type of treatment option that they are looking for,” said Gitte Aabo, President and CEO of LEO Pharma. “At LEO Pharma, we are committed to providing patients with innovative, new solutions and we believe the foam formulation of Enstilar can help patients living with psoriasis.” Enstilar was developed to treat patients with psoriasis vulgaris2,3 – the most common clinical form of psoriasis.4 The U.S. approval of Enstilar was ... Read more

Related support groups: Psoriasis, Plaque Psoriasis, Enstilar, Betamethasone/Calcipotriene

Worse Psoriasis, Less Healthy Arteries, Study Finds

Posted 8 Oct 2015 by Drugs.com

THURSDAY, Oct. 8, 2015 – The skin disorder psoriasis appears linked with artery inflammation, raising the odds for heart disease, a new study says. "As the amount of psoriasis increases, the amount of blood vessel inflammation increases," said senior investigator Dr. Nehal Mehta, a clinical investigator with the U.S. National Heart, Lung, and Blood Institute. His team also found that even mild psoriasis may indicate an increased risk for heart attack and stroke. Just one psoriasis skin patch, or plaque, "might be biologically active, causing low-grade inflammation and starting a cascade, speeding up their blood vessel disease," Mehta said. "People really should know that psoriasis is not just a cosmetic disease," he added. However, these study findings only show an association between psoriasis and blood vessel inflammation, not a direct cause-and-effect relationship, Mehta said. His ... Read more

Related support groups: Methotrexate, Psoriasis, Inflammatory Conditions, Plaque Psoriasis, Coronary Artery Disease (CAD), Soriatane, Tazorac, Dovonex, Acute Coronary Syndrome, Taclonex, Oxsoralen, Acitretin, Resorcinol, Calcipotriene, Tazarotene, Acute Coronary Syndrome - Prophylaxis, Anthralin, Vectical, Dritho-Scalp, Psoriatec

Ask a Question

Further Information

Related Condition Support Groups

Plaque Psoriasis, Psoriasis

Related Drug Support Groups

Taclonex, Enstilar, Taclonex Scalp, Dovobet

Betamethasone / Calcipotriene Patient Information at Drugs.com